Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2025-12-24 @ 7:23 PM
NCT ID:
NCT02822703
Eligibility Criteria:
Inclusion Criteria:
* 21-65 years old
* Are fluent in English and be able to read English at the 8th grade level
* Pass the Transcranial Magnetic Stimulation Adult Safety and Screening Questionnaire (TASS)
* Report smoking 5-20 cigarettes daily
* Intend to quit smoking in the next 30 days
* Report a motivation level to quit of ≥7 (scale 0-10)
* Pass a urine drug screen for drugs of abuse (marijuana, cocaine, opioids, amphetamines, etc.)
* No plans to move from the area NYC area in the next 4 months and have a consistent, reliable method of communication so that study staff can successfully contact them
Exclusion Criteria:
* self-reported claustrophobia
* personal history of epilepsy
* use of anticonvulsant medication
* head injury, aneurysm, stroke, or previous cranial neurosurgery
* diagnosis of major depressive disorder, bipolar disorder, a schizophrenia-spectrum disorder, tinnitus, or migraines
* metal implants in the head, neck, or cochlea; a pacemaker
* currently taking medications that lower seizure threshold (i.e., such as tricyclic antidepressants or bupropion)
* known pre-existing noise induced hearing loss or concurrent treatment of ototoxic medications (i.e., Aminoglycosides, Cisplatine)
* currently using medications for tobacco cessation (i.e., nicotine replacement, bupropion, varenicline, etc.)
* pregnant or planning to become pregnant in the next 12 weeks
* current regular use of forms of tobacco other than cigarettes
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
65 Years
Study:
NCT02822703
Study Brief:
Protocol Section:
NCT02822703